[[{“value”:”
James Burt, Chair of the Value Added Medicines Sector Group at Medicines for Europe shares his vision how off-patent innovation can help sustainably address today’s major public health needs such as antimicrobial resistance, cardiovascular disease or the burden on health systems.
Through the EU pharmaceutical legislation, addressing the market failure which has long blocked off-patent innovation is within reach.
Medicines for Europe is calling for all types of repurposed medicines to be considered in Article 84, while only rewarding those which prove they significant patient benefits and address important public health needs.
In these videos, James shares his view on the ways we can bring the best out of existing pharmaceuticals and bring those benefits to patients.
We give you energy news and help invest in energy projects too, click here to learn more
Crude Oil, LNG, Jet Fuel price quote
ENB Top News
ENB
Energy Dashboard
ENB Podcast
ENB Substack
The post Delivering Benefits for Patients and health systems through value added medicines [Promoted content] appeared first on Energy News Beat.
“}]]